Publications of the Eichmüller group (since 2010)

Requesting PDFs

All reprints are available as PDF for personal use on request

Most recent publications

Asterisks delineate equal contribution.


  • Eisel D, Das K, Dickes E, König R, Osen W, and Eichmüller SB (2019) Cognate interaction with CD4+ T cells instructs tumor-associated macrophages to acquire M1-like phenotype. Front Immunol 10(219). Link to full text
  • Sharbi-Yunger A, Grees M, Gal C, Bassan D, Eichmüller SB, Tzehoval E, Utikal J, Umansky V, and Eisenbach L (2019) A universal anti-cancer vaccine: chimeric invariant chain potentiates the inhibition of melanoma progression and improvement of survival. Int J Cancer 144: 909-921.


  • Ast V*, Kordaß T*, Oswald M, Kolte A, Eisel D, Osen W, Eichmüller SB, Berndt A, and König R (2018) MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion. Oncotarget 9: 35559-35580. Link to full text
  • Kordaß T, Weber CEM, Eisel D, Pane AA, Osen W, and Eichmüller SB (2018) miR‑193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion. Oncotarget 9(65): 32507-32522. Link to full text
  • Kordaß T, Osen W, and Eichmüller SB (2018) Controlling the immune suppressor: transcription factors and miRNAs regulating CD73/NT5E. Frontiers in Immunology, 9(813). Review. Link to full text
  • Grees M et al. (2018) Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. Oncoimmunology 7(7): e1445457. Link to full text
  • Michels J et al. (2018) Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC 18961 trial. Oncoimmunology 7: e1428157. Link to full text
  • Krackhardt AM et al. (2018) Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies - the German Cancer Consortium approach. Cancer Immunol Immun 67(4):513-523. (request reprint)
  • Lv N et al. (2018) miR-137 inhibits melanoma cell proliferation through downregulation of GLO1. Sci China Life Sci 61: 541-549. Link to full text or request reprint


  • Das K*, Eisel D*, et al. (2017) Generation of murine β2-microglobulin deficient tumor cell lines using the CRISPR/Cas9 system. PLoS ONE 12: e0174077. Link to full text
  • Eichmüller SB, Osen W, Mandelboim O, and Seliger B (2017) Immune modulatory microRNAs involved in tumor attack and tumor immune escape. J Natl Cancer Inst. Link to full text



  • Weber CEM et al. (2016) miR-339-3p is a tumor suppressor in melanoma. Cancer Res 76: 3562-3571. Link to full text.
  • Werner S et al. (2016) Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. Scientific Reports 6: 25467. Link to full text.
  • Kordaß T et al. (2016) SOX5 is involved in balanced MITF regulation in human melanoma cells. BMC Med Genomics 9: 10. Link to full text.
  • Chen H et al. (2016) Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Oncotarget 7: 16420-32. Link to full text.


  • Gardyan A*, Osen W* et al. (2015) Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice. Int J Cancer 136: 2588-97.
  • Zörnig I et al. (2015) Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients. Int J Cancer 136: 138-51.
  • Pfirschke C et al. (2015) T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response. Cancer Immunol Immunother 64: 1369-81.
  • Lei J et al. (2015) Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy. Plos One 10: e0138458.
  • Hao S et al. (2015) miR-137 inhibits proliferation of melanoma cells by targeting PAK2. Exp Dermatol 24: 947-52.
  • Amann PM et al. (2015) LRAT overexpression diminishes intracellular levels of biologically active retinoids and reduces retinoid anti-tumor efficacy in the murine melanoma B16F10 cell line. Skin Pharmacol Physiol 28: 205-12.


  • Schumacher T et al. (2014) A vaccine targeting mutant IDH1 induces antitumor immunity. Nature 512: 324-7.
  • Schacht T et al. (2014) Estimating the activity of transcription factors by the effect on their target genes. Bioinformatics 30: i401-i7.
  • Luo C et al. (2014) The role of microRNAs in melanoma. Eur J Cell Biol 93: 11-22.
  • Amann PM et al. (2014) Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells. Exp Dermatol 23: 832-7.


  • Simon-Keller K et al. (2013) Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholin receptor-redirected T cells. Am J Pathol 182: 2121-31.
  • Luo C et al. (2013) miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J Invest Dermatol 133: 768-75.
  • Luo C et al. (2013) MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. Cancer Letters 341: 240-7.
  • Hassel JC et al. (2013) Lecithin/retinol acyltransferase as a potential prognostic marker for malignant melanoma. Exp Dermatol 22: 757-9.


  • Savchenko MS et al. (2012) Autoantibodies against a Ca2+-binding protein recoverin in blood sera of patients with various oncological diseases. Oncology Letters 3: 377-82.
  • Grund SE et al. (2012) Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells. Neoplasia 14: 238-48.
  • Bai AH et al. (2012) MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol 123: 529-38.
  • Amann PM et al. (2012) Vitamin A metabolism in benign and malignant skin cells: Importance of lecithin/retinol acyltransferase and RPE65. J Cell Physiol 227: 718-28.
  • Amann PM et al. (2012) Expression and activity of alcohol and aldehyde dehydrogenases in melanoma cells and in melanocytes. J Cell Biochem 113: 792-9.
  • Abschuetz O*, Osen W* et al. (2012) T-cell mediated immune responses induced in ret transgenic mouse model of malignant melanoma. Cancers 4: 490-503.

Before 2012

See complete list of all publications by Stefan Eichmüller (PDF file).

to top